Potential role of Borreria hispida in ameliorating cardiovascular risk factors

Journal of Cardiovascular Pharmacology

Volumn 53, Issue 6, 2009, Pages 499-506

  Vasanthi, Hannah R ^a   Mukherjee, Subhendu ^b   Lekli, Istvan ^b   Ray, Diptarka ^b   Veeraraghavan, Gayathri ^a   Das, Dipak K ^b  

^a SRI RAMACHANDRA UNIVERSITY   (India)

^b UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Borreria hispida; Cardioprotection; Ischemia; Reperfusion; Survival signal

Indexed keywords

BUFFER; CASPASE 3; CYTOCHROME C; GLUCOSE TRANSPORTER 4; HEME OXYGENASE 1; HERBACEOUS AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN TYROSINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BORRERIA HISPIDA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVATION; HEART INFARCTION SIZE; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; RISK FACTOR; RUBIACEAE; SURVIVAL;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL SURVIVAL; HEART; HEME OXYGENASE-1; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PHOSPHORYLATION; PLANT COMPONENTS, AERIAL; PLANT EXTRACTS; PPAR DELTA; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY; RISK FACTORS; RUBIACEAE; SIGNAL TRANSDUCTION;

EID: 68249103436     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3181a7b677     Document Type: Article

References (36)

1. Reich DE, Lander ES. On the allelic spectrum of human disease. Trends Genet. 2001;17:502-510.
2. Kaplan JC, Junien C. Genomics and medicine: an anticipation. From Boolean Mendelian genetics to multifactorial molecular medicine. Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie. 2000;323:1167-1174.
3. Loktionov A. Common gene polymorphisms and nutrition: emerging links with pathogenesis of multifactorial chronic diseases. J Nutr Biochem. 2003;14:426-451. (Pubitemid 37020963)
4. Morphy R, Kay C, Rankovic Z. From magic bullets to designed multiple ligands. Drug Discov Today. 2004;9:641-651. (Pubitemid 38981718)
5. Zhang HY. One-compound-multiple-targets strategy to combat Alzheimer's disease. FEBS Lett. 2005;579:5260-5264. (Pubitemid 41398143)
6. Balunas MJ, Kinghorn AD. Drug discovery from medicinal plants. Life Sci. 2005;78:431-441.
7. Itokawa H, Susan L, Natschke M, et al. Plant-derived natural product research aimed at new drug discovery. Nat Med (Tokyo). 2008;62: 263-280.
8. Warrior PK, Nambiar VPK, Ramankutty C. Indian Medicinal Plants. Vol 2. Hyderabad, India: Orient Longman Ltd; 1994.
9. Mudalair MKS. Gunapadam (Materia medica)-Mooligai Vagupu. 7th ed. Directorate of Indian Medicine and Homeopathy; 2003;554.
10. Anshurathi Rao CV, Khatoon S, Mehrotra S. Ethno pharmacological evaluation of Peristrophe bicalyculata Nees for anti-inflammatory and analgesic activity. Nat Prod Sci. 2003;9:195-199. (Pubitemid 37254404)
11. Harborne JB. Phytochemical Methods: A Guide to Modern Techniques of Plant Analysis. 3rd ed. Dordrecht, The Netherlands: Kluwer Academic Publishers; 1998.
12. Lekli I, Das S, Das S, et al. Coenzyme Q9 provides cardioprotection after converting into coenzyme Q10. J Agric Food Chem. 2008;56:5331-5337.
13. Engelman DT, Watanabe M, Engelman RM, et al. Hypoxic preconditioning preserves antioxidant reserve in the working rat heart. Cardiovasc Res. 1995;29:133-140.
14. Mukherjee S, Lekli I, Das M, et al. Cardioprotection with alphatocopheryl phosphate: amelioration of myocardial ischemia reperfusion injury is linked with its ability to generate a survival signal through Akt activation. Biochim Biophys Acta. 2008;1782:498-503.
15. Sato M, Cordis GA, Maulik N, et al. SAPK's regulation of ischemic preconditioning. Am J Physiol. 2000;279:H901-H907.
16. Patwardhan B,Warude D, Pushpangadan P, et al. Ayurveda and traditional Chinese medicine: a comparative overview. Evid Based Complement Alternat Med. 2005;2:465-474. (Pubitemid 41752482)
17. Goldman P. Herbal medicines today and the roots of modern pharmacology. Ann Inter Med. 2001;135:594-600. (Pubitemid 33010195)
18. Schmidt BM, Ribnicky DM, Lipsky PE, et al. Revisiting the ancient concept of botanical therapeutics. Nat Chem Biol. 2007;3:360-365.
19. Huang TH, Kota BP, Razmovski V. Herbal or natural medicines as modulators of peroxisome proliferator-activated receptors and related nuclear receptors for therapy of metabolic syndrome. Basic Clin Pharmacol Toxicol. 2005;96:13-14. (Pubitemid 40260842)
20. Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998;281: 1309-1312.
21. Wolter KG, Hsu YT, Carolyn L, et al. Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol. 1997;139:1281-1292.
22. Ichikawa N, Nakabayashi K, Hashimoto T. Ayeast mitochondrial ATPase inhibitor interacts with three proteins that are easy to dissociate from the mitochondrial inner membrane. Biochem J. 2002;132:649-654. (Pubitemid 35238920)
23. Waterhouse NJ, Goldstein JC, von Ahsen O, et al. Cytochrome c maintains mitochondrial transmembrane potential and ATP generation after outer mitochondrial membrane permeabilization during the apoptotic process. J Cell Biol. 2001;153:319-328.
24. Gomez-Lazaro M, Galindo MF, Melero-Fernandez de Mera RM, et al. Reactive oxygen species and p38 mitogen-activated protein kinase activate Bax to induce mitochondrial cytochrome c release and apoptosis in response to malonate. Mol Pharmacol. 2007;71:736-743. (Pubitemid 46294084)
25. Das DK, Maulik N. Conversion of death signal into survival signal by redox signaling. Biochemistry. 2004;69:10-17.
26. Gurusamy N, Malik G, Gorbunov NV, et al. Redox activation of Ref-1 potentiates cell survival following myocardial ischemia reperfusion injury. Free Radic Biol Med. 2007;43:397-407. (Pubitemid 46977631)
27. Schlessinger J. New roles for Src kinases in control of cell survival and angiogenesis. Cell. 2000;100:293-296. (Pubitemid 30353084)
28. Hattori R, Otani H, Uchiyama T, et al. Src tyrosine kinase is the trigger but not the mediator of ischemic preconditioning. Am J Physiol. 2001;281: H1066-H1074. (Pubitemid 33775157)
29. Idriss NK, Blann AD, Lip GY. Hemoxygenase-1 in cardiovascular disease. J Am Coll Cardiol. 2008;52:971-978.
30. Andreadi CK, Howells LM, Atherfold PA, et al. Involvement of Nrf2, p38, B-Raf, and nuclear factor-kappa B, but not phosphatidylinositol 3-kinase, in induction of hemeoxygenase-1 by dietary polyphenols. Mol Pharmacol. 2006;69:1033-1073.
31. Cao Z, Ye P, Long C, et al. Effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on ischemia-reperfusion injury in rats. Pharmacology. 2007;79:184-192. (Pubitemid 46631932)
32. Yue TL, Nerurkar SS, Bao W, et al. In vivo activation of proliferatoractivated receptor delta protects the heart from ischemia/reperfusion injury in Zucker fatty rats. J Pharmacol Exp Ther. 2008;325:466-474.
33. Pesant M, Sueur S, Dutartre P, et al. Peroxisome proliferator-activated receptor delta (PPARdelta) activation protects H9c2 cardiomyoblasts from oxidative stress-induced apoptosis. Cardiovasc Res. 2006;69: 440-449. (Pubitemid 43098800)
34. Fliegner D, Westermann D, Riad A, et al. Up-regulation of PPARgamma in myocardial infarction. Eur J Heart Fail. 2008;10:30-38.
35. King LM, Opie LH. Glucose delivery is a major determinant of glucose utilisation in the ischemic myocardium with a residual coronary flow. Cardiovasc Res. 1998;39:381-392.
36. Lekli I, Szabo G, Juhasz B, et al. Protective mechanisms of resveratrol against ischemia-reperfusion-induced damage in hearts obtained from Zucker obese rats: the role of GLUT-4 and endothelin. Am J Physiol Heart Circ Phys. 2008;294:H859-H866. (Pubitemid 351253297)